{"component": "definition", "props": {"groups": [{"snippet": "means a Biologics License Application under the United States\u2019 Public Health Services Act and Federal Food, Drug and Cosmetics Act, each as amended, and the regulations promulgated thereunder, or a comparable filing seeking Regulatory Approval in any country.", "samples": [{"hash": "fUvXMzvzTG7", "uri": "/contracts/fUvXMzvzTG7#bla", "label": "License Agreement (Telix Pharmaceuticals LTD)", "score": 35.7926063538, "published": true}, {"hash": "jqumDPrWSg6", "uri": "/contracts/jqumDPrWSg6#bla", "label": "License Agreement (Telix Pharmaceuticals LTD)", "score": 35.6995201111, "published": true}, {"hash": "7iDlIDtCTqW", "uri": "/contracts/7iDlIDtCTqW#bla", "label": "License Agreement (Telix Pharmaceuticals LTD)", "score": 35.3737182617, "published": true}], "snippet_links": [{"key": "biologics-license-application", "type": "definition", "offset": [8, 37]}, {"key": "the-united-states", "type": "definition", "offset": [44, 61]}, {"key": "health-services-act", "type": "definition", "offset": [70, 89]}, {"key": "as-amended", "type": "definition", "offset": [137, 147]}, {"key": "the-regulations", "type": "clause", "offset": [153, 168]}, {"key": "regulatory-approval", "type": "definition", "offset": [224, 243]}], "size": 243, "hash": "119a5fd0192d59b3cc4e7879a332344e", "id": 1}, {"snippet": "means a complete biologics license application as defined in, and containing the content, and in the format, required by 21 C.F.R. \u00a7 600 et seq filed with the FDA, or a corresponding application with a Regulatory Authority in a country other than the United States, together with all replacements, additions, deletions, and supplements thereto.", "samples": [{"hash": "84KgHjqRqR6", "uri": "/contracts/84KgHjqRqR6#bla", "label": "Research Collaboration and License Agreement (AC Immune SA)", "score": 27.6995201111, "published": true}, {"hash": "jP428uhHxV5", "uri": "/contracts/jP428uhHxV5#bla", "label": "Research Collaboration and License Agreement (AC Immune SA)", "score": 27.4120464325, "published": true}, {"hash": "btHBgzctqz2", "uri": "/contracts/btHBgzctqz2#bla", "label": "Research Collaboration and License Agreement (AC Immune SA)", "score": 26.8945922852, "published": true}], "snippet_links": [{"key": "biologics-license-application", "type": "definition", "offset": [17, 46]}, {"key": "the-content", "type": "clause", "offset": [77, 88]}, {"key": "required-by", "type": "definition", "offset": [109, 120]}, {"key": "the-fda", "type": "clause", "offset": [155, 162]}, {"key": "regulatory-authority", "type": "clause", "offset": [202, 222]}, {"key": "the-united-states", "type": "definition", "offset": [247, 264]}], "size": 133, "hash": "3f2c9f4753d3424b518a1c8050cd08dd", "id": 2}, {"snippet": "means a Biologics License Application, for which Regulatory Approval by the FDA is required to market a Product in the U.S.", "samples": [{"hash": "iUNmoR2wqWA", "uri": "/contracts/iUNmoR2wqWA#bla", "label": "Collaboration and License Agreement (Ambrx Biopharma Inc.)", "score": 32.4031486511, "published": true}, {"hash": "dCQF4sNilTb", "uri": "/contracts/dCQF4sNilTb#bla", "label": "Collaboration and License Agreement (Ambrx Biopharma Inc.)", "score": 32.4031486511, "published": true}, {"hash": "gYVTh1S5WGx", "uri": "/contracts/gYVTh1S5WGx#bla", "label": "Collaboration and License Agreement (Ambrx Biopharma Inc.)", "score": 32.2005462646, "published": true}], "snippet_links": [{"key": "biologics-license-application", "type": "definition", "offset": [8, 37]}, {"key": "approval-by", "type": "clause", "offset": [60, 71]}, {"key": "the-fda", "type": "clause", "offset": [72, 79]}, {"key": "market-a", "type": "definition", "offset": [95, 103]}, {"key": "the-us", "type": "clause", "offset": [115, 122]}], "size": 126, "hash": "b19871e60717be6d57be6d709474ec00", "id": 3}, {"snippet": "means a biologics license application, or similar application, submitted to a Regulatory Authority.", "samples": [{"hash": "l5LSaNnCMh6", "uri": "/contracts/l5LSaNnCMh6#bla", "label": "License, Development, and Commercialization Agreement", "score": 31.3408622742, "published": true}, {"hash": "eCSkbMXzK8w", "uri": "/contracts/eCSkbMXzK8w#bla", "label": "License, Development and Commercialization Agreement (Provention Bio, Inc.)", "score": 29.4435310364, "published": true}, {"hash": "eLimqmxB79F", "uri": "/contracts/eLimqmxB79F#bla", "label": "License, Development, and Commercialization Agreement (Provention Bio, Inc.)", "score": 29.3504447937, "published": true}], "snippet_links": [{"key": "biologics-license-application", "type": "definition", "offset": [8, 37]}, {"key": "regulatory-authority", "type": "clause", "offset": [78, 98]}], "size": 91, "hash": "9f981e2f2a942af747bfc10aeb649cd6", "id": 4}, {"snippet": "means a Biologics License Application (as defined in 21 C.F.R. 600 et. seq.), MAA or substantially similar application or submission filed with a Regulatory Authority in a country or group of countries to obtain Regulatory Approval to market a product in that country or in that group of countries, and any amendments thereto.", "samples": [{"hash": "fyyY1aCKvdq", "uri": "/contracts/fyyY1aCKvdq#bla", "label": "Collaboration Agreement (Voyager Therapeutics, Inc.)", "score": 26.8453121185, "published": true}, {"hash": "d4YNOZGiWoQ", "uri": "/contracts/d4YNOZGiWoQ#bla", "label": "Collaboration Agreement (Voyager Therapeutics, Inc.)", "score": 26.8398361206, "published": true}, {"hash": "6A88nyJpxXr", "uri": "/contracts/6A88nyJpxXr#bla", "label": "Collaboration Agreement (Voyager Therapeutics, Inc.)", "score": 26.7686519623, "published": true}], "snippet_links": [{"key": "biologics-license-application", "type": "definition", "offset": [8, 37]}, {"key": "substantially-similar", "type": "definition", "offset": [85, 106]}, {"key": "regulatory-authority", "type": "clause", "offset": [146, 166]}, {"key": "regulatory-approval", "type": "definition", "offset": [212, 231]}, {"key": "market-a", "type": "definition", "offset": [235, 243]}], "size": 80, "hash": "4024dce66b49cbd985c4a1287a125f33", "id": 5}, {"snippet": "means a biologics license application (as defined in Title 21 of the United States Code of Federal Regulations, as amended from time to time) filed with the FDA seeking Regulatory Approval to market and sell any Licensed Product in the United States for a particular indication within the Field.", "samples": [{"hash": "kbF9uAM26ER", "uri": "/contracts/kbF9uAM26ER#bla", "label": "Patent License Agreement (Tharimmune, Inc.)", "score": 35.8501014709, "published": true}, {"hash": "hv2HWe87HJD", "uri": "/contracts/hv2HWe87HJD#bla", "label": "Development and License Agreement (ImmunoGen, Inc.)", "score": 33.1587944031, "published": true}, {"hash": "fJKOwu9ELUr", "uri": "/contracts/fJKOwu9ELUr#bla", "label": "Exclusive License Agreement (Stemline Therapeutics Inc)", "score": 23.4668045044, "published": true}], "snippet_links": [{"key": "biologics-license-application", "type": "definition", "offset": [8, 37]}, {"key": "united-states-code-of-federal-regulations", "type": "definition", "offset": [69, 110]}, {"key": "as-amended", "type": "definition", "offset": [112, 122]}, {"key": "from-time-to-time", "type": "clause", "offset": [123, 140]}, {"key": "the-fda", "type": "clause", "offset": [153, 160]}, {"key": "regulatory-approval", "type": "definition", "offset": [169, 188]}, {"key": "licensed-product", "type": "definition", "offset": [212, 228]}, {"key": "in-the-united-states", "type": "clause", "offset": [229, 249]}, {"key": "the-field", "type": "definition", "offset": [285, 294]}], "size": 71, "hash": "2d33b095233c2b6c394cb8ce85fdd914", "id": 6}, {"snippet": "means basic liquidity adjustment which is 0% or 25% as determined by Fitch in accordance with the Fitch Criteria;", "samples": [{"hash": "3RB1LJ8s1kt", "uri": "/contracts/3RB1LJ8s1kt#bla", "label": "Credit Support Annex", "score": 36.4224319458, "published": true}, {"hash": "7LvaQjHwcvM", "uri": "/contracts/7LvaQjHwcvM#bla", "label": "Credit Support Annex", "score": 35.6568908691, "published": true}, {"hash": "fQ1W45eJ9me", "uri": "/contracts/fQ1W45eJ9me#bla", "label": "Credit Support Annex", "score": 35.5409507751, "published": true}], "snippet_links": [{"key": "liquidity-adjustment", "type": "definition", "offset": [12, 32]}, {"key": "in-accordance-with", "type": "definition", "offset": [75, 93]}, {"key": "fitch-criteria", "type": "definition", "offset": [98, 112]}], "size": 54, "hash": "2738ebab0f45a7b64e0fec2109f26df4", "id": 7}, {"snippet": "means a Biologics License Application, or similar application that is submitted to the FDA, or a foreign equivalent of the FDA, for marketing approval of a Licensed Product in a country (or region).", "samples": [{"hash": "dyNtwV5j8S8", "uri": "/contracts/dyNtwV5j8S8#bla", "label": "License and Collaboration Agreement (Globeimmune Inc)", "score": 25.3832988739, "published": true}, {"hash": "jRAp8GQuEZr", "uri": "/contracts/jRAp8GQuEZr#bla", "label": "License and Collaboration Agreement (Globeimmune Inc)", "score": 25.2053394318, "published": true}, {"hash": "bUNjJBBp5cE", "uri": "/contracts/bUNjJBBp5cE#bla", "label": "License and Collaboration Agreement (Globeimmune Inc)", "score": 23.6228618622, "published": true}], "snippet_links": [{"key": "biologics-license-application", "type": "definition", "offset": [8, 37]}, {"key": "the-fda", "type": "clause", "offset": [83, 90]}, {"key": "foreign-equivalent", "type": "definition", "offset": [97, 115]}, {"key": "approval-of", "type": "definition", "offset": [142, 153]}, {"key": "licensed-product", "type": "definition", "offset": [156, 172]}], "size": 48, "hash": "1edf178b679e8fc45911b06a76749a24", "id": 8}, {"snippet": "means a \u201cBiologics License Application\u201d (as more fully defined in 21 U.S.C. \u00a7262(a)(2)(C), 21 C.F.R. 601.2(a), or their successor provisions) seeking Marketing Authorization of a Product and all amendments and supplements thereto filed with the FDA with respect to a Product, or an equivalent application filed with a Regulatory Authority in a country other than the United States to market a biopharmaceutical product.", "samples": [{"hash": "cnHISgtsnou", "uri": "/contracts/cnHISgtsnou#bla", "label": "Platform Technology Transfer and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "18jSgCdp6xa", "uri": "/contracts/18jSgCdp6xa#bla", "label": "Platform Technology Transfer and License Agreement (Zymeworks Inc.)", "score": 28.2525672913, "published": true}, {"hash": "5HH2Q2snB0U", "uri": "/contracts/5HH2Q2snB0U#bla", "label": "Platform Technology Transfer and License Agreement (Zymeworks Inc.)", "score": 28.2142372131, "published": true}], "snippet_links": [{"key": "biologics-license-application", "type": "definition", "offset": [9, 38]}, {"key": "successor-provisions", "type": "definition", "offset": [120, 140]}, {"key": "marketing-authorization", "type": "clause", "offset": [150, 173]}, {"key": "amendments-and-supplements", "type": "clause", "offset": [195, 221]}, {"key": "the-fda", "type": "clause", "offset": [241, 248]}, {"key": "with-respect-to", "type": "clause", "offset": [249, 264]}, {"key": "regulatory-authority", "type": "clause", "offset": [318, 338]}, {"key": "the-united-states", "type": "definition", "offset": [363, 380]}, {"key": "market-a", "type": "definition", "offset": [384, 392]}], "size": 42, "hash": "60c3ec0d8e9bc347ea4e6a153916c1b1", "id": 9}, {"snippet": "means a Biologic License Application (as more fully described in U.S. 21 C.F.R. Part 601.20 or its successor regulation), as may be amended from time to time, or any analogous application or submission with any Regulatory Authority outside of the United States.", "samples": [{"hash": "jKuRDnzYZ3e", "uri": "/contracts/jKuRDnzYZ3e#bla", "label": "License and Collaboration Agreement (Tempest Therapeutics, Inc.)", "score": 37.2409324646, "published": true}, {"hash": "71IbTpMkion", "uri": "/contracts/71IbTpMkion#bla", "label": "Exclusive License and Collaboration Agreement (Tempest Therapeutics, Inc.)", "score": 37.2409324646, "published": true}, {"hash": "62bJpWkQVkQ", "uri": "/contracts/62bJpWkQVkQ#bla", "label": "License Agreement (Precision Biosciences Inc)", "score": 35.234085083, "published": true}], "snippet_links": [{"key": "biologic-license-application", "type": "definition", "offset": [8, 36]}, {"key": "from-time-to-time", "type": "clause", "offset": [140, 157]}, {"key": "regulatory-authority", "type": "clause", "offset": [211, 231]}, {"key": "outside-of-the-united-states", "type": "clause", "offset": [232, 260]}], "size": 40, "hash": "307903c7dab026ae6179f83f8119264f", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMYmxhIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means a Biologics License Application under the United States\u2019 Public Health Services Act and Federal Food, Drug and Cosmetics Act, each as amended, and the regulations promulgated thereunder, or a comparable filing seeking Regulatory Approval in any country.", "size": 1868, "title": "BLA", "id": "bla", "examples": ["If such termination occurs after the COMPANY files a <strong>BLA</strong> with the FDA (or foreign equivalent) for a Licensed Product, then in addition to the preceding, COMPANY shall also pay to EMORY a termination fee of LIC.18.023 [****], provided that a Licensed Patent has issued covering the Licensed Product in the Licensed Territory for which the <strong>BLA</strong> (or foreign equivalent) is sought."], "related": [["drug-approval-application", "Drug Approval Application", "Drug Approval Application"], ["ind", "IND", "IND"], ["regulatory-approval-application", "Regulatory Approval Application", "Regulatory Approval Application"], ["nda", "NDA", "NDA"], ["anda", "ANDA", "ANDA"]], "related_snippets": [], "updated": "2026-05-29T05:44:52+00:00"}, "json": true, "cursor": ""}}